ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AVCT Avacta

44.00
0.75 (1.73%)
Last Updated: 08:19:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.75 1.73% 44.00 43.00 45.00 44.00 43.25 43.25 290,844 08:19:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 23.25M -24.95M -0.0695 -6.33 155.29M
Avacta is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 43.25p. Over the last year, Avacta shares have traded in a share price range of 39.75p to 139.00p.

Avacta currently has 359,042,104 shares in issue. The market capitalisation of Avacta is £155.29 million. Avacta has a price to earnings ratio (PE ratio) of -6.33.

Avacta Share Discussion Threads

Showing 80476 to 80498 of 81050 messages
Chat Pages: Latest  3230  3229  3228  3227  3226  3225  3224  3223  3222  3221  3220  3219  Older
DateSubjectAuthorDiscuss
14/9/2024
16:30
lol 1347....er, so you don't know the answer or have any evidence despite writing with such authority. Rajraj's possible explanation sounds plausible but no doubt that'll be 'confirmation bias'.
cheshire pete
14/9/2024
12:18
If they had found the MTD at a much lower dose the trial would have finished P1 ages ago but the expectation of what the potential is here would then be poor so I'm all for it taking its time for this particular reason.
rajraj b
14/9/2024
12:11
I think they didn't expect not to find a MTD. this is what has slowed everything down. Even in the 2 week trial they haven't found a MTD. Yes it slows the process down as you would do your best to identify it. Pretty impressive stuff.
rajraj b
14/9/2024
09:53
@cp Well you'd have to ask Avacta that, they are running the trials, but I bet you won't get an answer. Possibly they could have modelled it to get to the optimum dosage quicker rather than everything being done empirically and sequentially. It's not normal for Phase 1 trials to take over 3 years.
1347
14/9/2024
08:40
It Works™
vertizeasun
14/9/2024
07:47
https://avacta.com/wp-content/uploads/2024/09/Twelves-et-al-2024-ESMO-poster.pdf
rajraj b
14/9/2024
07:34
https://avacta.com/avacta-reports-updated-phase-1-clinical-data-of-ava6000-at-the-european-society-for-medical-oncology-esmo-congress-demonstrating-multiple-ongoing-durable-responses-in-solid-tumors/
rajraj b
14/9/2024
07:26
Yes the Covid test lost out by Johnson importing millions of tests from China through a £50 off the shelf company, and when challenged in the Commons shouting that he supported the British diagnostic sector
The Scots producer of tests was then taken over by the Chinese for a pittance

sandcrab2
13/9/2024
21:19
We may not have long to wait for the data. Timescales dictated by regulatory and medical requirements rather than satisfying the impatient looking for the next quick buck or short trade. Do you have evidence 1347 that things could have been done quicker?

Chartists saying 200 day moving average crossed recently lol.

cheshire pete
13/9/2024
20:28
Same question to you then 1347. What's not to like?
cheshire pete
13/9/2024
18:25
People buying on an article by MM, a known ramper, who has been proven to be wrong time after time, what could possibly go wrong?
1347
13/9/2024
17:31
Even when Avct is taken over, he will argue against it.
divmad
13/9/2024
17:23
Jaknife: Are you saying there's something in the above by MM that you think is incorrect? If so, pray tell the rest of us.
cheshire pete
13/9/2024
15:57
Then go by what Avacta is saying publicly in its R&D notes and the Esmo conf data.
divmad
13/9/2024
15:51
Jaknife , erm Covid , really
jacktrax
13/9/2024
15:05
Powerful summation by Myles there
sandcrab2
13/9/2024
14:27
Who to believe: Jaknife, repins, whitey, MylesM?

Know where my money is.

Should add copied from LSE.

cheshire pete
13/9/2024
12:57
"So, whilst in 2033/34 (approximately when the family of patents expire for the D-Ala-Pro substrate), other companies may start to use the 1stgeneration format for developing PDCs, they could not develop 2nd generation PDCs (unless under license from Avacta or whoever owns the technology then). And why bother attempting to develop a 1st generation PDC in the mid-2030s, when the owner of the 2nd generation technology (which would be on-patent for another decade at that point) could simply develop a superior molecule?"
vertizeasun
13/9/2024
07:04
Cheshire/ Fieldhouse ...I do understand your enthusiasm, really I do. Things look spot on. Data looks good, cash position looks ok for now etc.
I just can't work out why the main guy walked- his baby etc+ when on the cusp of a major breakthrough, more share options etc etc.
I detest Aim. It s bandit country. Many pi.s lose their pants and are never seen again. Must have a well balanced portfolio but greedy takes most.
We wait.
Good luck fellas ...
Ps share price is strong/ steady

amanitaangelicus
12/9/2024
19:55
Am,Smiths comment that a fundraise was nothing to worry about when the share price was north of a £ and then raise at 50p was UNFORGIVABLE.Big investors would have wanted his head . Simple
fieldhouse
12/9/2024
19:26
No idea why he stepped down ama, could have been for many reasons. Careful with those conspiracy theories though. AIM has seen some great companies start up, Avacta could be the next.
cheshire pete
12/9/2024
18:35
Poster presentation this weekend, should see a Monday company update.
robers98
12/9/2024
18:09
THE AVCT SHARE PRICE

And when they were up they were up,
And when they were down they were down,
And when they were only half way up
They were neither up nor down.


RESULTS SHOULD SOON CLARIFY share price DIRECTION

GOOD LUCK ALL

waldron
Chat Pages: Latest  3230  3229  3228  3227  3226  3225  3224  3223  3222  3221  3220  3219  Older

Your Recent History

Delayed Upgrade Clock